Merck Serono fined for promoting drug

MERCK Serono has been fined $20,000 over a news item that was found to have been promoting the drug Movectro directly to the general public.

The company was originally fined $75,000 under the Medicines Australia Code of Conduct, but that amount was reduced on appeal.